Mutant-selective AKT inhibition through lysine targeting and neo-zinc chelation.
Craven GB, Chu H, Sun JD, Carelli JD, Coyne B, Chen H, Chen Y, Ma X, Das S, Kong W, Zajdlik AD, Yang KS, Reisberg SH, Thompson PA, Lipford JR, Taunton J.
Craven GB, et al. Among authors: ma x.
Nature. 2024 Nov 6. doi: 10.1038/s41586-024-08176-4. Online ahead of print.
Nature. 2024.
PMID: 39506119